Chengdu Kanghong Pharmaceutical Group Co., Ltd

SZSE:002773 Stock Report

Market Cap: CN¥17.5b

Chengdu Kanghong Pharmaceutical Group Valuation

Is 002773 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002773 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002773 (CN¥19.01) is trading below our estimate of fair value (CN¥54.07)

Significantly Below Fair Value: 002773 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002773?

Key metric: As 002773 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002773. This is calculated by dividing 002773's market cap by their current earnings.
What is 002773's PE Ratio?
PE Ratio14.7x
EarningsCN¥1.19b
Market CapCN¥17.48b

Price to Earnings Ratio vs Peers

How does 002773's PE Ratio compare to its peers?

The above table shows the PE ratio for 002773 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27.7x
300558 Betta Pharmaceuticals
44.9x26.7%CN¥20.7b
000739 Apeloa PharmaceuticalLtd
17x17.9%CN¥18.2b
600129 Chongqing Taiji Industry(Group)Ltd
22.5x31.0%CN¥13.7b
600329 Tianjin Pharmaceutical Da Ren Tang Group
26.5x20.8%CN¥21.5b
002773 Chengdu Kanghong Pharmaceutical Group
14.7x13.4%CN¥17.5b

Price-To-Earnings vs Peers: 002773 is good value based on its Price-To-Earnings Ratio (14.7x) compared to the peer average (27.7x).

Price to Earnings Ratio vs Industry

How does 002773's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
002773 14.7xIndustry Avg. 29.6xNo. of Companies31PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 002773 is good value based on its Price-To-Earnings Ratio (14.7x) compared to the CN Pharmaceuticals industry average (31.1x).

Price to Earnings Ratio vs Fair Ratio

What is 002773's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002773 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.7x
Fair PE Ratio25x

Price-To-Earnings vs Fair Ratio: 002773 is good value based on its Price-To-Earnings Ratio (14.7x) compared to the estimated Fair Price-To-Earnings Ratio (25x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

China Resources Double-Crane PharmaceuticalLtd

CN¥21.4b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

CN¥20.80

7D

-3.9%

1Y

12.1%

Jiangsu Kanion PharmaceuticalLtd

CN¥8.1b

Researches and develops, produces, and sells Chinese medicines.

600557

CN¥14.29

7D

-4.2%

1Y

-23.6%

Dong-E-E-JiaoLtd

CN¥36.4b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

423

CN¥56.60

7D

-3.0%

1Y

13.2%